Company intelligence / Profile preview

Quotient Diagnostics

West Molesey, Surrey, United Kingdomselectscience.net ↗

Ownership: Private
Development stage: Other

Overview

Quotient Diagnostics developed and commercialized a patented fluorescent assay platform for rapid measurement of hemoglobin A1c and other markers used in the diagnosis and management of diabetes. Their products were clinically validated and used internationally prior to acquisition/dissolution.

Therapeutic areas: Endocrinology
Modalities: DeviceDiagnostic assay
Industry: Protein Biomarker Diagnostics

Beyond the preview

Go deeper on Quotient Diagnostics.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Quotient Diagnostics.

Explore the full profile